Welcome to Valneva
A leading pure play vaccine company.
— June 30, 2017
Valneva Announces Successful Outcome of its AGM and the Appointment of two new Supervisory Board Members; The Company Confirms its Growth Strategy and R&D OutlookRead more
— April 18, 2017
Valneva Announces Signing of a New EB66® Commercial License with Bavarian Nordic
Valneva's CEO Thomas Lingelbach
comments on Group Strategy
— Product pipeline
Our goal is to develop and launch a continuous flow of products. We strive for a balance between in-house development and strategic partnerships to accelerate vaccine development.
– Upcoming conferences and fairs
11th Vaccine Congress
San Diego, US
September 17-20, 2017
World Vaccine Congress Europe
October 10-12, 2017
21st World Congress and Exhibition on Vaccines, Vaccination & Immunization
November 16-17, 2017
A leading pure play vaccine company with international footprint.